Vasilis Stavrinides

Focal prostate HIFU 🎯 What an honour, privilege & pleasure to now re-join the renowned Imperial Prostate team @IP_London team as Hons Consultant Urological Surgeon & deliver focal therapy! Very grateful to have been welcomed back warmly, and to help give best possible outcomes for our patients @ImperialSandC @ImperialNHS @FocalSociety @UkFocal @LondonProstate1 @TaimurShah

If you are a clinician interested in prostate cancer research, imaging, pathology, data analysis and translational work, take this opportunity to work in @uclmedsci @AttardLab @ReIMAGINE_PCa group! Only a few days left to apply! ucl.ac.uk/work-at-ucl/se…

My meager education in biology and evolution gave me the mistaken impression that evolution optimized everything. But it didn't. One example is the recurrent laryngeal nerve (RLN). It goes from behind your ear, loops down below your aorta, and then back up to the voice-box 1/2

ucl.ac.uk/work-at-ucl/se…+

If you are a clinician interested in prostate cancer research, imaging and translational work, take this opportunity to work in our @uclmedsci @AttardLab @ReIMAGINE_PCa group! Only a few days left to apply! uk.indeed.com/m/viewjob?jk=1…

Let's kill the real monster...the prostate cancer. #17 at Speed mentoring session at #PCFRetreat23 @PCF_Science @TylerSbrt @RenuEapen @DrSpratticus @AmarUKishan @VStavrinides #PCSM

Our new paper on MRI follow up of targeted biopsy-negative prostate lesions is out! @mrsprostate @giga_fra @Norapashayan @ShonitP @EmbertonMark @Finnsense @UKRI_News @turinginst @PCFnews @CRUKresearch @EurUrolFocus authors.elsevier.com/sd/article/S24…

At BBC for @BBCr4today interview on how we’re doing better with a safer, more accurate & less harmful pathway MRI, targeted biopsy and focal therapy @IP_London @imperialurology @ImperialSandC @imperialcollege @ImperialNHS @ProstateUK Time point:2:48. bbc.co.uk/sounds/play/m0…

Merry Xmas!

In 161 men from the PROMIS trial, prostate zones that contained Gleason score 3+4 cancer were 3x more likely to be MRI-positive than benign zones and almost 9x if they had a Gleason score ≥4+3. @VStavrinides @MrJosephNorris @giga_fra @IP_London @The_MRC bit.ly/3UWgbhr

Dr. Harmath discusses prospective validation of MRI signal abnormalities and clinically significant cancer in this editorial. bit.ly/3FEGF1a

In our latest @radiology_rsna paper we estimate the impact of prostate cancer burden on odds of MRI positivity! Many thanks to co-authors @MrJosephNorris @giga_fra @SolonSTATS @UCLLifeSciences @turinginst @EmbertonMark @LondonProstate1 pubs.rsna.org/doi/10.1148/ra…

Schrödinger's Plates: They are both broken and not broken until you open the door.

A diver in Belize has made friends with an octopus. She named him Egbert and brings him treats in his own jar. (Video Elora Kooistra)

From @SigridCarlsson - “if it ain’t broke don’t fix it” genomic testing in AS. RE: genomic differences based on MR-conspicuity: should we be deciding on genomic testing based on MR characteristics & targeting? 1/2 @cooperberg_ucsf @MrJosephNorris @VStavrinides @b3nsimp #EAU22

Excellent @Uroweb session by @RannikkoAntti on the future of PSA density kinetics! Our MRI-based AS work on the topic might just be on the right track @giga_fra @mrsprostate @uclh @UCLDivofSurgery pubmed.ncbi.nlm.nih.gov/33958731/

The #AUA22 with a European twist 🇬🇧 🇮🇹 🇧🇪 🇵🇱 🇪🇺 @BWHUrology @ucl @HUNIMED @orsiacademy

Current Issue: Magnetic Resonance Imaging–guided Active Surveillance of Prostate Cancer: Time to Say Goodbye to Protocol-based Biopsies buff.ly/3Dk68LZ @giga_fra @VStavrinides @mrsprostate #MRI #prostatecancer #biopsies #openscience #openaccess #urology #MedTwitter

doi.org/10.1016/j.medi… If we are serious about using ML for some clinical tasks, a lot need to be redefined, e.g. what a good quality image is. Without noise or defect? or "good enough" for NNs to work with? @shaheersd has some interesting poitns in his new MedIA paper.